MedTrace Logo

A Clinical Trial to Evaluate Dichloroacetate (DCA) as a Treatment for Endometriosis-associated Pain

NCT04046081 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-06-13

No results posted yet for this study

Summary

This is a single-arm open label exploratory clinical trial to evaluate dichloroacetate (DCA) as a possible treatment for treatment of endometriosis-associated pain

Conditions

  • Endometriosis

Interventions

DRUG

Dichloroacetate

6.25 mg/kg BD for 6 weeks increasing to 12.5 mg/kg BD for 6 weeks

Sponsors & Collaborators

  • University of Nottingham

    collaborator OTHER

  • Ferring Pharmaceuticals

    collaborator INDUSTRY

  • University of Birmingham

    collaborator OTHER

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Andrew W Horne, Prof · University of Edinburgh

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-19
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04046081 on ClinicalTrials.gov